Pay in 4 interest-free payments of $5.82 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
You can also look on the manufacturer website for instructions or videos
Australia GLP-1 Receptor Agonist Market Growth Factors Increased adoption of GLP-1 receptor agonists: The safety and efficacy of GLP-1 receptor agonists for type 2 diabetes and obesity management is increasing the demand and adoption in the Australian population
Comparative effectiveness of DPP-4 inhibitors versus sulfonylurea for the treatment of type 2 diabetes in routine clinical practice: A retrospective multicenter real-world study
These datasets include: in vivo data for the mouse studies and encompass metabolic, biochemical and histological data/images
US$ 23.46
US$ 21.10
US$ 27.20
US$ 26.04
US$ 21.41
